Evaluating CMR

Metabolic Syndrome and Type 2 Diabetes/CVD Risk

NCEP-ATP III

The NCEP-ATP III Statement of 2001

Page: Go to Previous Page 3 of 11 Go to Next Page
Associations of metabolic syndrome components with criteria for the clinical diagnosis of the metabolic syndrome as proposed by the NCEP-ATP III Table: Associations of metabolic syndrome components with criteria for the clinical diagnosis of the metabolic syndrome as proposed by the NCEP-ATP III

Associations of metabolic syndrome components with criteria for the clinical diagnosis of the metabolic syndrome as proposed by the NCEP-ATP III Table: Associations of metabolic syndrome components with criteria for the clinical diagnosis of the metabolic syndrome as proposed by the NCEP-ATP III

These criteria are presented in Table. As outlined in the table, the metabolic syndrome is diagnosed if patients have three or more risk factors/markers, with the syndrome increasing CHD risk at any given LDL cholesterol level. However, these clinical tools are not a definition of the metabolic syndrome. NCEP-ATP III also recommends managing the metabolic syndrome for two reasons: to target the underlying causes of the metabolic syndrome (obesity and physical inactivity) and to treat nonlipid and lipid risk factors. Furthermore, NCEP-ATP III suggests that treatment of the metabolic syndrome should begin with lifestyle therapy aimed at achieving a healthy body weight.

Page: Go to Previous Page 3 of 11 Go to Next Page
Print this document